Histrelin (acetate)
98%
- Product Code: 108515
CAS:
220810-26-4
| Molecular Weight: | 1323.5 g./mol | Molecular Formula: | C₆₆H₈₆N₁₈O₁₂XC₂H₄O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Histrelin acetate is primarily used in medical treatments, particularly in the management of hormone-sensitive conditions. It is commonly employed in the treatment of advanced prostate cancer, where it helps to reduce the levels of testosterone, thereby slowing the progression of the disease.
In addition to its use in prostate cancer, histrelin acetate is also utilized in the treatment of central precocious puberty (CPP) in children. By suppressing the production of sex hormones, it delays the onset of puberty, allowing for more typical physical and emotional development.
The chemical is administered through implants or injections, providing a controlled and sustained release of the active ingredient. This method ensures consistent hormone suppression over an extended period, reducing the need for frequent dosing and improving patient compliance.
Overall, histrelin acetate plays a crucial role in managing conditions that are driven by excessive or premature hormone production, offering patients a more controlled and effective treatment option.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Powder |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | £775.76 |
+
-
|
| 0.020 | 10-20 days | £1,375.11 |
+
-
|
Histrelin (acetate)
Histrelin acetate is primarily used in medical treatments, particularly in the management of hormone-sensitive conditions. It is commonly employed in the treatment of advanced prostate cancer, where it helps to reduce the levels of testosterone, thereby slowing the progression of the disease.
In addition to its use in prostate cancer, histrelin acetate is also utilized in the treatment of central precocious puberty (CPP) in children. By suppressing the production of sex hormones, it delays the onset of puberty, allowing for more typical physical and emotional development.
The chemical is administered through implants or injections, providing a controlled and sustained release of the active ingredient. This method ensures consistent hormone suppression over an extended period, reducing the need for frequent dosing and improving patient compliance.
Overall, histrelin acetate plays a crucial role in managing conditions that are driven by excessive or premature hormone production, offering patients a more controlled and effective treatment option.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :